Table 1.
Baseline characteristics (n = 69)
| Characteristics | Value |
|---|---|
| Age, years |
|
| Median age |
61.0 |
| Range |
39–89 |
| Gender, n (%) |
|
| Male |
47 (68) |
| Female |
22 (32) |
| ECOG performance status, n (%) |
|
| 0 |
47 (78) |
| 1 |
13 (22) |
| TN clinical stage, n (%) |
|
| T2N1-N2 |
2 (3) |
| T3N0 |
12 (17) |
| T3N1-N2 |
44 (64) |
| T4N0 |
3 (4) |
| T4N1-N2 |
4 (6) |
| M clinical stage, n (%) |
|
| Mx |
10 (14) |
| M0 |
57 (83) |
| M1 |
2 (3) |
| Tumor distance from anal verge, n (%) |
|
| Mean ± SD (cm) |
5.92 ± 3.68 |
| Upper third (≥12 cm) |
20 (33) |
| Middle third (6–12 cm) |
26 (42) |
| Lower third (≤6 cm) | 27 (43) |
Abbreviation: ECOG = Eastern Cooperative Oncology Group.
Data presented as number of patients, with percentages in parentheses.